368 related articles for article (PubMed ID: 10772947)
21. OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology.
Ishii N; Takahashi T; Soroosh P; Sugamura K
Adv Immunol; 2010; 105():63-98. PubMed ID: 20510730
[TBL] [Abstract][Full Text] [Related]
22. Contribution of CD30/CD153 but not of CD27/CD70, CD134/OX40L, or CD137/4-1BBL to the optimal induction of protective immunity to Mycobacterium avium.
Flórido M; Borges M; Yagita H; Appelberg R
J Leukoc Biol; 2004 Nov; 76(5):1039-46. PubMed ID: 15316035
[TBL] [Abstract][Full Text] [Related]
23. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine.
Liu J; Ngai N; Stone GW; Yue FY; Ostrowski MA
Vaccine; 2009 Aug; 27(37):5077-84. PubMed ID: 19573639
[TBL] [Abstract][Full Text] [Related]
24. Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses.
Gramaglia I; Weinberg AD; Lemon M; Croft M
J Immunol; 1998 Dec; 161(12):6510-7. PubMed ID: 9862675
[TBL] [Abstract][Full Text] [Related]
25. Expression of tumour necrosis factor (TNF) ligand superfamily co-stimulatory molecules CD30L, CD27L, OX40L, and 4-1BBL in murine hearts with acute myocarditis caused by Coxsackievirus B3.
Seko Y; Takahashi N; Oshima H; Shimozato O; Akiba H; Takeda K; Kobata T; Yagita H; Okumura K; Azuma M; Nagai R
J Pathol; 2001 Dec; 195(5):593-603. PubMed ID: 11745696
[TBL] [Abstract][Full Text] [Related]
26. OX40 (CD134) engagement drives differentiation of CD4+ T cells to effector cells.
Huddleston CA; Weinberg AD; Parker DC
Eur J Immunol; 2006 May; 36(5):1093-103. PubMed ID: 16541471
[TBL] [Abstract][Full Text] [Related]
27. Negative regulation of IL-17 production by OX40/OX40L interaction.
Li J; Li L; Shang X; Benson J; Merle Elloso M; Schantz A; Bracht M; Orlovsky Y; Sweet R
Cell Immunol; 2008; 253(1-2):31-7. PubMed ID: 18501882
[TBL] [Abstract][Full Text] [Related]
28. Expression of OX40 ligand in microglia activated by IFN-gamma sustains a protective CD4+ T-cell response in vitro.
Wang Y; Li M; Song M; Xu X; Xiong J; Yang X; Tan J; Bai Y
Cell Immunol; 2008 Feb; 251(2):86-92. PubMed ID: 18485335
[TBL] [Abstract][Full Text] [Related]
29. Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis.
Weinberg AD; Wegmann KW; Funatake C; Whitham RH
J Immunol; 1999 Feb; 162(3):1818-26. PubMed ID: 9973447
[TBL] [Abstract][Full Text] [Related]
30. Blockade of the OX40 ligand prolongs corneal allograft survival.
Hattori T; Usui Y; Okunuki Y; Sonoda Y; Usui M; Takada E; Mizuguchi J; Yagita H; Okumura K; Akiba H; Takeuchi M
Eur J Immunol; 2007 Dec; 37(12):3597-604. PubMed ID: 18022861
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo activities of OX40 (CD134)-IgG fusion protein isoforms with different levels of immune-effector functions.
Taylor L; Bachler M; Duncan I; Keen S; Fallon R; Mair C; McDonald TT; Schwarz H
J Leukoc Biol; 2002 Sep; 72(3):522-9. PubMed ID: 12223520
[TBL] [Abstract][Full Text] [Related]
32. Expression and function of the OX40/OX40L costimulatory pair during herpes stromal keratitis.
Lepisto AJ; Xu M; Yagita H; Weinberg AD; Hendricks RL
J Leukoc Biol; 2007 Mar; 81(3):766-74. PubMed ID: 17185358
[TBL] [Abstract][Full Text] [Related]
33. Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses.
Taraban VY; Rowley TF; O'Brien L; Chan HT; Haswell LE; Green MH; Tutt AL; Glennie MJ; Al-Shamkhani A
Eur J Immunol; 2002 Dec; 32(12):3617-27. PubMed ID: 12516549
[TBL] [Abstract][Full Text] [Related]
34. 4-1BB and OX40 stimulation enhance CD8 and CD4 T-cell responses to a DNA prime, poxvirus boost vaccine.
Munks MW; Mourich DV; Mittler RS; Weinberg AD; Hill AB
Immunology; 2004 Aug; 112(4):559-66. PubMed ID: 15270726
[TBL] [Abstract][Full Text] [Related]
35. Cloning of mouse Ox40: a T cell activation marker that may mediate T-B cell interactions.
Calderhead DM; Buhlmann JE; van den Eertwegh AJ; Claassen E; Noelle RJ; Fell HP
J Immunol; 1993 Nov; 151(10):5261-71. PubMed ID: 8228223
[TBL] [Abstract][Full Text] [Related]
36. Intracellular signaling of gp34, the OX40 ligand: induction of c-jun and c-fos mRNA expression through gp34 upon binding of its receptor, OX40.
Matsumura Y; Hori T; Kawamata S; Imura A; Uchiyama T
J Immunol; 1999 Sep; 163(6):3007-11. PubMed ID: 10477563
[TBL] [Abstract][Full Text] [Related]
37. Characterization and application of two novel monoclonal antibodies against human OX40: costimulation of T cells and expression on tumor as well as normal gland tissues.
Xie F; Wang Q; Chen Y; Gu Y; Shi Q; Ge Y; Yu G; Wu H; Mao Y; Wang X; Zhou Y; Zhang X
Tissue Antigens; 2006 Apr; 67(4):307-17. PubMed ID: 16634867
[TBL] [Abstract][Full Text] [Related]
38. Costimulation through OX40 is crucial for induction of an alloreactive human T-cell response.
Ukyo N; Hori T; Yanagita S; Ishikawa T; Uchiyama T
Immunology; 2003 Jun; 109(2):226-31. PubMed ID: 12757617
[TBL] [Abstract][Full Text] [Related]
39. Thiol levels in CD134-defined subsets of rat T lymphocytes: possible implications for HgCl2-induced immune dysregulation.
Roos A; Claessen N; Schilder-Tol EJ; Chand MA; Weening JJ; Aten J
Biochem Biophys Res Commun; 1997 Nov; 240(2):452-7. PubMed ID: 9388500
[TBL] [Abstract][Full Text] [Related]
40. CD4 T cell traffic control: in vivo evidence that ligation of OX40 on CD4 T cells by OX40-ligand expressed on dendritic cells leads to the accumulation of CD4 T cells in B follicles.
Brocker T; Gulbranson-Judge A; Flynn S; Riedinger M; Raykundalia C; Lane P
Eur J Immunol; 1999 May; 29(5):1610-6. PubMed ID: 10359115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]